David Langleben
- Pulmonary and Respiratory Medicine top 0.05%
- Pulmonary Hypertension Research and Treatments 135
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 9
- Respiratory Support and Mechanisms 6
-
- Cardiovascular Issues in Pregnancy 45
- Cardiovascular Function and Risk Factors 26
- Heart Failure Treatment and Management 26
- Genetics top 0.2%
- Vascular Anomalies and Treatments 14
- Hepatology top 0.5%
- Internal Medicine top 1%
-
- Nitric Oxide and Endothelin Effects 14
- Co-authors
- Robert D. LevyLewis J. RubinNazzareno GalièDavid B. BadeschGérald SimonneauDuncan J. StewartRobyn J. BarstMaurice Beghetti
- Journals
- CHEST Journal (22 papers)European Respiratory Journal (10 papers)The Journal of Heart and Lung Transplantation (8 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
David Langleben
156 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Pulmonary and Respiratory Medicine 12.3k
- Cardiology and Cardiovascular Medicine 8.2k
- Genetics 2.2k
- Hepatology 1.3k
- Internal Medicine 395
Countries citing papers authored by David Langleben
This map shows the geographic impact of David Langleben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Langleben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Langleben more than expected).
Fields of papers citing papers by David Langleben
This network shows the impact of papers produced by David Langleben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Langleben. The network helps show where David Langleben may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Langleben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 6 | |
| 9 | 2019 | 13 | |
| 10 | The RESPITE Study: Riociguat In Patients With Pah And An Inadequate Response To Phosphodiesterase 5 Inhibitors | 2016 | 2 |
| 11 | 2015 | 72 | |
| 12 | 2014 | 10 | |
| 13 | 2014 | 3 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 5 | |
| 16 | 2013 | 0 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 1 | |
| 19 | 2005 | 6 | |
| 20 | Sitaxsentan Therapy for Pulmonary Arterial Hypertensionbreakdown → | 2003 | 540 |
About David Langleben
David Langleben is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics, having authored 163 papers that have together received 14.3k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (135 papers), Cardiovascular Issues in Pregnancy (45 papers), Cardiovascular Function and Risk Factors (26 papers), Heart Failure Treatment and Management (26 papers), Nitric Oxide and Endothelin Effects (14 papers), Vascular Anomalies and Treatments (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Respiratory Support and Mechanisms (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (12.3k citations), Cardiology and Cardiovascular Medicine (8.2k citations) and Genetics (2.2k citations). David Langleben has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Robert D. Levy, Lewis J. Rubin, Nazzareno Galiè, David B. Badesch, Gérald Simonneau, Duncan J. Stewart, Robyn J. Barst, Maurice Beghetti, Stuart Rich and Zhi‐Cheng Jing. Their work appears in journals such as CHEST Journal, European Respiratory Journal, The Journal of Heart and Lung Transplantation, Canadian Journal of Cardiology and Pulmonary Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.